Sam Radwan examines China's economic challenges, including a housing downturn, weak consumer confidence, and the country's largest credit contraction in two decades. He explains why policymakers face limited options as growth slows and yield differentials widen. Radwan also highlights China's rapidly expanding biopharma industry, which is emerging as one of the country's most promising growth stories.